Reducing Cell Culture Contamination: Why Sterilisation Validation Matters in CO₂ Shaking Workflows

Why It Matters

Validated full‑chamber sterilisation dramatically lowers the probability of hidden microbial contamination, safeguarding costly biologics projects and accelerating development timelines. Labs that adopt such technology can improve data reliability and reduce repeat experiments.

Key Takeaways

• CO₂ shaker incubators foster microbial growth in hidden chamber zones
• UV decontamination only reaches line‑of‑sight surfaces, leaving residues untreated
• CellXpert CS220 delivers validated 180 °C full‑chamber sterilisation
• Validation used Bacillus atrophaeus indicators across hard‑to‑reach spots
• Routine aseptic technique remains essential despite advanced sterilisation equipment

Pulse Analysis

Contamination in suspension cultures of CHO or HEK293 cells is a silent threat that can derail weeks of work. Standard cleaning regimes rely on UV light and HEPA filtration, but these methods are limited by line‑of‑sight exposure and focus on airborne microbes. As a result, moisture, condensation, and residual media in recessed zones of CO₂ incubator shakers become breeding grounds for bacteria and fungi, leading to subtle phenotype shifts or outright assay failures that are costly to troubleshoot.

Eppendorf’s CellXpert® CS220 tackles this gap by delivering a high‑temperature, 180 °C sterilisation cycle that treats the entire chamber, including the stainless‑steel shaking platform and otherwise inaccessible corners. The process was rigorously validated using Bacillus atrophaeus biological indicators positioned throughout the chamber, and third‑party verification confirms compliance with sterility assurance levels expected in regulated environments. This full‑chamber approach eliminates the blind spots left by UV and HEPA solutions, providing a reproducible, validated method that integrates seamlessly with routine cleaning via removable components and a hygienic chamber design.

For biotech and pharmaceutical labs, the operational impact is significant. By reducing the incidence of hidden contamination, teams can trust their cell‑based data, shorten project timelines, and lower the cost of repeat experiments. Adoption of validated sterilisation also aligns with Good Manufacturing Practice (GMP) expectations, supporting smoother transitions from research to production. As the industry pushes toward higher throughput and automation, technologies like the CS220 set a new baseline for aseptic assurance in cell culture workflows.